We serve Chemical Name:methyl 4-fluoropyridine-2-carboxylate CAS:886371-79-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 4-fluoropyridine-2-carboxylate
CAS.NO:886371-79-5
Synonyms:Methyl 4-fluoropicolinate;4-Fluoro-2-pyridinecarboxylic acid methyl ester;4-fluoropyridine-2-carboxylic acid methyl ester
Molecular Formula:C7H6FNO2
Molecular Weight:155.12600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:39.19000
Exact Mass:155.03800
LogP:1.00730
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Methyl 4-fluoropicolinate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-fluoropyridine-2-carboxylic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Fluoro-2-pyridinecarboxylic acid methyl ester Use and application,4-Fluoro-2-pyridinecarboxylic acid methyl ester technical grade,usp/ep/jp grade.
Related News: This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire. methyl 4-fluoropyridine-2-carboxylate manufacturer Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act. methyl 4-fluoropyridine-2-carboxylate supplier Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. methyl 4-fluoropyridine-2-carboxylate vendor Last month, Emergent Chief Executive Robert Kramer said it was his understanding that there are 100 million doses of J&J’s vaccine ready for FDA review and that regulators had begun the review process. methyl 4-fluoropyridine-2-carboxylate factory This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.
